HI

Hadley Iliff

Vice President, Regulatory Affairs And Product Safety at Merz Pharma

Hadley Iliff has a strong background in regulatory affairs and product safety. Hadley is currently serving as the Vice President of Regulatory Affairs and Product Safety at Merz Therapeutics since January 2023. Prior to this role, they held the position of Senior Director and Director of Regulatory Affairs and Product Safety at Merz Therapeutics from 2021 to 2023. Hadley also worked as the Director of US Regulatory Affairs at Merz Therapeutics from 2020 to 2021. Before joining Merz Therapeutics, Hadley worked at Merz North America as a Regulatory Affairs Manager from 2019 to 2020. Hadley also served as a Senior Regulatory Affairs Specialist and Regulatory Affairs Specialist at the same company from 2016 to 2019 and from 2014 to 2016 respectively. Hadley's career started at the University of North Carolina at Greensboro as a Research Associate in Biochemistry from 2013 to 2014. Hadley also gained experience as a Customer Service Representative at Great Harvest Bread Co. during the same period.

Hadley Iliff completed their education history as follows:

Hadley Iliff earned a Bachelor of Arts degree in Biochemistry from Oberlin College, which they attended from 2005 to 2009. They then pursued a Master of Arts degree in Biochemistry at Duke University from 2010 to 2013. Subsequently, from 2013 to 2016, Hadley Iliff attended the University of North Carolina at Greensboro, where they obtained a Master of Business Administration degree.

In addition to their academic achievements, Hadley Iliff obtained a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS) in April 2022.

Links

Previous companies

UNCG logo

Timeline

  • Vice President, Regulatory Affairs And Product Safety

    January, 2023 - present

  • Senior Director Regulatory Affairs And Product Safety

    August, 2021

  • Director Regulatory Affairs And Product Safety

    January, 2021

  • Director US Regulatory Affairs

    January, 2020

View in org chart